Matthew Larson files Form 144 to sell 58,502 shares
Matthew Larson proposes to sell 58,502 shares of Common Stock under a Form 144 notification related to the exercise of stock options.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Matthew Larson proposes to sell 58,502 shares of Common Stock under a Form 144 notification related to the exercise of stock options. The filing lists multiple prior 10b5-1 sales by Larson in March–April 2026, with individual trades such as 44,752 shares sold on 04/29/2026 for $895,939.52.
The transaction is processed through Morgan Stanley Smith Barney LLC. The Form 144 shows sale dates and per-trade proceeds for recent 10b5-1 transactions; timing and additional conditions are as stated in the filing.
Insights
Routine Form 144 reporting of option-related sales under a 10b5-1 plan.
The filing documents a proposed sale of 58,502 shares from an exercise of stock options and lists multiple executed 10b5-1 sales in March–April 2026. The broker listed is Morgan Stanley Smith Barney LLC.
Observers should note that the presence of a 10b5-1 sales schedule typically indicates pre-arranged dispositions; the filing itself lists per-trade shares and proceeds but does not state broader financial impact.
Key Figures
Key Terms
10b5-1 regulatory
Exercise of Stock Options financial
Form 144 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does Matthew Larson's Form 144 for SLDE report?
Which broker is handling the reported sale in Form 144 for SLDE?
Were there recent 10b5-1 sales by Matthew Larson before this Form 144?
Does the Form 144 state how proceeds will be used?
AI-generated analysis. How Rhea-AI works. Not financial advice.